Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof; Commission Determination Not To Review an Initial Determination Granting the Complainants' Motion to Amend the Complaint and Notice of Investigation to Substitute U.S. Patent No. Re44,453 For U.S. Patent No. 7,614,398 and Granting Respondents' Motion to Terminate the Investigation With Respect to U.S. Patent No. 7,614,398, 9000-9001 [2014-03246]

Download as PDF 9000 Federal Register / Vol. 79, No. 31 / Friday, February 14, 2014 / Notices subpart I, as amended. ONRR requests that only one transaction be used for payment of the four-fifths bonus bid amount and the first year’s rental. XI. Delay of Sale The BOEM Gulf of Mexico RD has the discretion to change any date, time, and/or location specified in the Final NOS Package in case of an event that the BOEM Gulf of Mexico RD deems may interfere with the carrying out of a fair and proper lease sale process. Such events could include, but are not limited to, natural disasters (e.g., earthquakes, hurricanes, and floods), wars, riots, acts of terrorism, fires, strikes, civil disorder, or other events of a similar nature. In case of such events, bidders should call (504) 736–0557, or access the BOEM Web site at http:// www.boem.gov for information regarding any changes. Dated: February 6, 2014. Tommy P. Beaudreau, Director, Bureau of Ocean Energy Management. [FR Doc. 2014–03316 Filed 2–13–14; 8:45 am] BILLING CODE 4310–MR–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 731–TA–986–987 (Second Review)] Ferrovanadium From China and South Africa: Notice of Commission Determination To Conduct Full FiveYear Reviews United States International Trade Commission. ACTION: Notice. AGENCY: The Commission hereby gives notice that it will proceed with full reviews pursuant to section 751(c)(5) of the Tariff Act of 1930 (19 U.S.C. 1675(c)(5)) to determine whether revocation of the antidumping duty orders on ferrovanadium from China and South Africa would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time. A schedule for the reviews will be established and announced at a later date. For further information concerning the conduct of these reviews and rules of general application, consult the Commission’s Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207, subparts A, D, E, and F (19 CFR part 207). DATES: Effective Date: February 4, 2014. FOR FURTHER INFORMATION CONTACT: Joanna Lo (202–205–1888), Office of mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:47 Feb 13, 2014 Jkt 232001 Investigations, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436. Hearingimpaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http:// www.usitc.gov). The public record for these reviews may be viewed on the Commission’s electronic docket (EDIS) at http://edis.usitc.gov. On February 4, 2014, the Commission determined that it should proceed to full reviews in the subject five-year reviews pursuant to section 751(c)(5) of the Act.1 The Commission found that the domestic interested party group response and the respondent interested party group response to its notice of institution (78 FR 65706, November 1, 2013) with respect to the review on ferrovanadium from South Africa were adequate, and decided to conduct a full review of that antidumping duty order. The Commission found that the respondent interested party group response with respect to the review on ferrovanadium from China was inadequate. However, the Commission determined to conduct a full review concerning the order on ferrovanadium from China to promote administrative efficiency in light of its decision to a conduct full review with respect to the order on subject imports from South Africa. A record of the Commissioners’ votes, the Commission’s statement on adequacy, and any individual Commissioner=s statements will be available from the Office of the Secretary and at the Commission’s Web site. SUPPLEMENTARY INFORMATION: Authority: These reviews are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.62 of the Commission’s rules. By order of the Commission. Issued: February 11, 2014. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2014–03262 Filed 2–13–14; 8:45 am] BILLING CODE P 1 Commissioner Shara L. Aranoff did not participate. PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–890] Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof; Commission Determination Not To Review an Initial Determination Granting the Complainants’ Motion to Amend the Complaint and Notice of Investigation to Substitute U.S. Patent No. Re44,453 For U.S. Patent No. 7,614,398 and Granting Respondents’ Motion to Terminate the Investigation With Respect to U.S. Patent No. 7,614,398 U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 7) of the presiding administrative law judge granting the Complainants’ motion to amend the complaint and notice of investigation to substitute claims 1–7 of U.S. Patent No. RE44,453 for claims 1–7 of U.S. Patent No. 7,614,398 (‘‘the ‘398 patent’’) and granting the Respondents’ motion to terminate the investigation with respect to the ‘398 patent. FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–3065. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on Friday, August 23, 2013, based on a complaint filed on July 19, 2013, on behalf of ResMed Corp. of San Diego, California; ResMed Inc. of San Diego, California; and ResMed Ltd. of Bella Vista, Australia (collectively, ‘‘the SUMMARY: E:\FR\FM\14FEN1.SGM 14FEN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 79, No. 31 / Friday, February 14, 2014 / Notices Complainants’’). 78 FR 52563–64 (August 23, 2013). The complaint alleged violations of Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the sale for importation, importation, or sale within the United States after importation of certain sleepdisordered breathing treatment systems and components thereof by reason of infringement of one or more of claims 32–37, 53, 79, 80, and 88 of U.S. Patent No. 7,997,267; claims 1–7 of U.S. Patent No. 7,614,398; claim 1 of U.S. Patent No. 7,938,116; claims 30, 37, and 38 of U.S. Patent No. 7,341,060; claims 1, 3, 5, 11, 28, 30, 31, and 56 of U.S. Patent No. 8,312,883; claims 13, 15, 16, 26–28, 51, 52, and 55 of U.S. Patent No. 7,926,487; claims 1, 3, 6, 7, 9, 29, 32, 35, 40, 42, 45, 50, 51, 56, 59, 89, 92, 94, and 96 of U.S. Patent No. 7,178,527; and claims 19–24, 26, 29–36, and 39–41 of U.S. Patent No. 7,950,392. The Commission’s notice of investigation named as respondents BMC Medical Co., Ltd. of Beijing, China; 3B Medical, Inc. of Lake Wales, Florida; and 3B Products, L.L.C. of Lake Wales, Florida (collective, ‘‘the Respondents’’). A Commission investigative attorney (‘‘IA’’) is also participating in this investigation. On December 13, 2013, the Commission issued notice of its determination not to review an ID (Order No. 4) granting the Complainants’ unopposed motion to amend the complaint to correct an error in its allegations regarding the domestic industry. 78 FR 76858–59 (December 19, 2013). On December 5, 2013, the Complainants filed a motion to amend the complaint and notice of investigation by substituting claim 1–7 of U.S. Patent No. RE44,453 for claims 1–7 of the ‘398 patent. On December 9, 2013, the Respondents filed a response in opposition to Complainants’ motion to amend and separately filed a motion to terminate the investigation, or in the alternative, for summary determination, with respect to the ‘398 patent. On December 26, 2013, the Commission investigative attorney filed a response in support of the Respondents’ motion to terminate and in opposition to the Complainants’ motion to amend the complaint and notice of investigation. On December 26, 2013, the Complainants filed a response to the Respondents’ motion. On January 9, 2014, the ALJ issued an ID (Order No. 7), granting the motion to amend the complaint and notice of investigation and granting the Respondents’ motion to terminate the investigation with respect to the ‘398 patent. No petitions for review were filed. VerDate Mar<15>2010 17:47 Feb 13, 2014 Jkt 232001 Having considered the ID, the Commission has determined not to review the subject ID. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and § 210.42 of the Commission’s Rules of Practice and Procedure (19 CFR 210.42). By order of the Commission. Issued: February 10, 2014. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2014–03246 Filed 2–13–14; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [OMB Number 1103–0105] Agency Information Collection Activities: Revision to a Currently Approved Collection; Comments Requested; Community Policing SelfAssessment (CP–SAT) ACTION: 60-day notice. The Department of Justice (DOJ) Office of Community Oriented Policing Services (COPS) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The information collection is published to obtain comments from the public and affected agencies. The purpose of this notice is to allow for 60 days for public comment until April 15, 2014. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Kimberly Brummett, Department of Justice Office of Community Oriented Policing Services, 145 N Street NE., Washington, DC 20530. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; PO 00000 Frm 00065 Fmt 4703 Sfmt 9990 9001 —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Revision of a currently approved collection; comments requested. (2) Title of the Form/Collection: Community Policing Self-Assessment (CP–SAT). (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: None. U.S. Department of Justice Office of Community Oriented Policing Services. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Law Enforcement Agencies and community partners. The purpose of this project is to improve the practice of community policing throughout the United States by supporting the development of a series of tools that will allow law enforcement agencies to gain better insight into the depth and breadth of their community policing activities. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply: It is estimated that approximately 95,035 respondents will respond with an average of 15 minutes per response. (6) An estimate of the total public burden (in hours) associated with the collection: The total estimated burden is 23,759 hours. If additional information is required contact: Jerri Murray, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Room 1407B, Washington, DC 20530. Dated: February 11, 2014. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2014–03261 Filed 2–13–14; 8:45 am] BILLING CODE 4410–AT–P E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 79, Number 31 (Friday, February 14, 2014)]
[Notices]
[Pages 9000-9001]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03246]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-890]


Certain Sleep-Disordered Breathing Treatment Systems and 
Components Thereof; Commission Determination Not To Review an Initial 
Determination Granting the Complainants' Motion to Amend the Complaint 
and Notice of Investigation to Substitute U.S. Patent No. Re44,453 For 
U.S. Patent No. 7,614,398 and Granting Respondents' Motion to Terminate 
the Investigation With Respect to U.S. Patent No. 7,614,398

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 7) of the presiding administrative law judge 
granting the Complainants' motion to amend the complaint and notice of 
investigation to substitute claims 1-7 of U.S. Patent No. RE44,453 for 
claims 1-7 of U.S. Patent No. 7,614,398 (``the `398 patent'') and 
granting the Respondents' motion to terminate the investigation with 
respect to the `398 patent.

FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on Friday, August 23, 2013, based on a complaint filed on July 19, 
2013, on behalf of ResMed Corp. of San Diego, California; ResMed Inc. 
of San Diego, California; and ResMed Ltd. of Bella Vista, Australia 
(collectively, ``the

[[Page 9001]]

Complainants''). 78 FR 52563-64 (August 23, 2013). The complaint 
alleged violations of Section 337 of the Tariff Act of 1930, as 
amended, 19 U.S.C. 1337, in the sale for importation, importation, or 
sale within the United States after importation of certain sleep-
disordered breathing treatment systems and components thereof by reason 
of infringement of one or more of claims 32-37, 53, 79, 80, and 88 of 
U.S. Patent No. 7,997,267; claims 1-7 of U.S. Patent No. 7,614,398; 
claim 1 of U.S. Patent No. 7,938,116; claims 30, 37, and 38 of U.S. 
Patent No. 7,341,060; claims 1, 3, 5, 11, 28, 30, 31, and 56 of U.S. 
Patent No. 8,312,883; claims 13, 15, 16, 26-28, 51, 52, and 55 of U.S. 
Patent No. 7,926,487; claims 1, 3, 6, 7, 9, 29, 32, 35, 40, 42, 45, 50, 
51, 56, 59, 89, 92, 94, and 96 of U.S. Patent No. 7,178,527; and claims 
19-24, 26, 29-36, and 39-41 of U.S. Patent No. 7,950,392. The 
Commission's notice of investigation named as respondents BMC Medical 
Co., Ltd. of Beijing, China; 3B Medical, Inc. of Lake Wales, Florida; 
and 3B Products, L.L.C. of Lake Wales, Florida (collective, ``the 
Respondents''). A Commission investigative attorney (``IA'') is also 
participating in this investigation.
    On December 13, 2013, the Commission issued notice of its 
determination not to review an ID (Order No. 4) granting the 
Complainants' unopposed motion to amend the complaint to correct an 
error in its allegations regarding the domestic industry. 78 FR 76858-
59 (December 19, 2013).
    On December 5, 2013, the Complainants filed a motion to amend the 
complaint and notice of investigation by substituting claim 1-7 of U.S. 
Patent No. RE44,453 for claims 1-7 of the `398 patent. On December 9, 
2013, the Respondents filed a response in opposition to Complainants' 
motion to amend and separately filed a motion to terminate the 
investigation, or in the alternative, for summary determination, with 
respect to the `398 patent. On December 26, 2013, the Commission 
investigative attorney filed a response in support of the Respondents' 
motion to terminate and in opposition to the Complainants' motion to 
amend the complaint and notice of investigation. On December 26, 2013, 
the Complainants filed a response to the Respondents' motion. On 
January 9, 2014, the ALJ issued an ID (Order No. 7), granting the 
motion to amend the complaint and notice of investigation and granting 
the Respondents' motion to terminate the investigation with respect to 
the `398 patent. No petitions for review were filed.
    Having considered the ID, the Commission has determined not to 
review the subject ID.
    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and Sec.  210.42 of 
the Commission's Rules of Practice and Procedure (19 CFR 210.42).

By order of the Commission.

    Issued: February 10, 2014.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2014-03246 Filed 2-13-14; 8:45 am]
BILLING CODE 7020-02-P